Beranda › Kanker Payudara › Washington › Tacoma
Uji klinis Kanker Payudara di Tacoma, WA
18 studi untuk Kanker Payudara mencari peserta di lokasi sekitar Tacoma (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
The Vanguard Study: Testing a New Way to Screen for Cancer
Menerima pesertaSukarelawan sehat diterima
- Madigan Army Medical Center, Tacoma
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Menerima pesertaFase 3
- Northwest Medical Specialties, Tacoma
- Providence Regional Cancer System, Lacey · 23 mi jauhnya
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Providence Regional Cancer System-Lacey, Lacey · 23 mi jauhnya
A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer
Menerima pesertaFase 3
- Research Site, Puyallup · 8 mi jauhnya
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
Menerima pesertaFase 2
- Northwest Medical Specialties, Puyallup · 8 mi jauhnya
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Menerima pesertaFase 3
- Northwest Medical Specialties, PLLC ( Site 0062), Tacoma
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Menerima pesertaFase 3
- Research Site, Tacoma
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Menerima pesertaFase 3
- Northwest Medical Specialties, Tacoma
- Northwest Medical Specialties, Gig Harbor · 8 mi jauhnya
- Northwest Medical Specialties, Puyallup · 8 mi jauhnya
- dan 1 lainnya
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Menerima pesertaFase 3
- Northwest Medical Specialties, PLLC ( Site 0067), Tacoma
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Menerima peserta
- MultiCare Cancer Institute, Tacoma
- Northwest Medical Specialties, PLLC, Puyallup · 8 mi jauhnya
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Menerima pesertaFase 3
- Clinical Trial Site, Olympia · 26 mi jauhnya
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Menerima pesertaFase 3
- MultiCare Health System, Tacoma
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Menerima pesertaFase 3
- Northwest Medical Specialties, PLLC, Tacoma
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Menerima pesertaFase 3
- MultiCare Cancer Institute - Tacoma, Tacoma
- Northwest Medical Specialties PLLC, Tacoma
- Vista Oncology, Olympia · 26 mi jauhnya
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Menerima pesertaFase 3
- Northwest Medical Specialties, Tacoma
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Menerima pesertaFase 3
- Providence Regional Cancer System-Lacey, Lacey · 23 mi jauhnya
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
Menerima pesertaFase 1/2
- Northwest Medical Specialties, PLLC, Tacoma
BostonGene and Exigent Genomic INsight Study
Menerima pesertaStudi observasional
- Northwest Medical Specialities, Puyallup · 8 mi jauhnya
Uji klinis Kanker Payudara di kota lain
- New York City, NY136 studi
- Houston, TX126 studi
- Boston, MA112 studi
- Nashville, TN81 studi
- Los Angeles, CA73 studi
- Edison, NJ68 studi
- St. Louis, MO64 studi
- Queens, NY64 studi
- Durham, NC64 studi
- Chicago, IL59 studi
- Philadelphia, PA56 studi
- Dallas, TX55 studi
Studi lain di Tacoma
- Kanker Paru Non-Sel Kecil20 studi
- Kolitis Ulseratif15 studi
- Mieloma Multipel13 studi
- Kanker Prostat11 studi
- Penyakit Crohn11 studi
- Kanker Kolorektal9 studi
- Kanker Metastatik9 studi
- Melanoma7 studi
- Kanker Ovarium7 studi
- Kanker Lambung6 studi
- Kanker Esofagus6 studi
- Kanker (semua jenis)6 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.